HK1000969A1 - Method for producing native hiv gp160 - Google Patents

Method for producing native hiv gp160

Info

Publication number
HK1000969A1
HK1000969A1 HK97102646A HK97102646A HK1000969A1 HK 1000969 A1 HK1000969 A1 HK 1000969A1 HK 97102646 A HK97102646 A HK 97102646A HK 97102646 A HK97102646 A HK 97102646A HK 1000969 A1 HK1000969 A1 HK 1000969A1
Authority
HK
Hong Kong
Prior art keywords
native hiv
producing native
hiv
producing
iii451
Prior art date
Application number
HK97102646A
Other languages
English (en)
Inventor
Mangalasseril G Sarngadharan
Vaniambadi S Kalyanaraman
Original Assignee
Akzo Nobel Nv
Sarngadharan Mangalasserill G
Vaniambadi S Kalyanaraman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sarngadharan Mangalasserill G, Vaniambadi S Kalyanaraman filed Critical Akzo Nobel Nv
Publication of HK1000969A1 publication Critical patent/HK1000969A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16—HIV-1 ; HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Element Separation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Physical Vapour Deposition (AREA)
HK97102646A 1988-08-16 1997-12-29 Method for producing native hiv gp160 HK1000969A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23285988A 1988-08-16 1988-08-16
US07/362,548 US5116740A (en) 1988-08-16 1989-06-07 Method for producing native hiv gp160

Publications (1)

Publication Number Publication Date
HK1000969A1 true HK1000969A1 (en) 1998-05-15

Family

ID=26926401

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97102646A HK1000969A1 (en) 1988-08-16 1997-12-29 Method for producing native hiv gp160

Country Status (10)

Country Link
US (1) US5116740A (xx)
EP (1) EP0394386B1 (xx)
KR (1) KR900702045A (xx)
AT (1) ATE127526T1 (xx)
AU (1) AU638214B2 (xx)
DE (1) DE68924155T2 (xx)
DK (1) DK175733B1 (xx)
FI (1) FI102684B1 (xx)
HK (1) HK1000969A1 (xx)
WO (1) WO1990002196A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254457A (en) * 1989-01-11 1993-10-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Monoclonal antibodies and method for identifying different aids-related viruses
ATE125157T1 (de) * 1990-04-03 1995-08-15 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
WO1992006220A1 (en) * 1990-10-05 1992-04-16 President And Fellows Of Harvard College Detection and isolation of ligands
NZ267838A (en) 1993-06-07 1997-12-19 Genentech Inc Preparation of an hiv gp 120 subunit vaccine involving determining a neutralising epitope in the v2 and/or c4 domains
US5736317A (en) * 1995-03-07 1998-04-07 Akzo Nobel N.V. Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
US20020155120A1 (en) * 1996-07-10 2002-10-24 Lowell George H. Protein and peptide vaccines for inducing mucosal immunity
CN1500806B (zh) * 2002-11-14 2010-05-05 上海科华生物工程股份有限公司 一种HIV－1ɡp160膜蛋白及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
WO1990002567A1 (en) * 1988-09-02 1990-03-22 The Ohio State University Research Foundation Virus-derived antigenic composition and its preparation and use

Also Published As

Publication number Publication date
ATE127526T1 (de) 1995-09-15
DK175733B1 (da) 2005-02-07
WO1990002196A1 (en) 1990-03-08
EP0394386A1 (en) 1990-10-31
US5116740A (en) 1992-05-26
FI102684B (fi) 1999-01-29
KR900702045A (ko) 1990-12-05
AU4068789A (en) 1990-03-23
AU638214B2 (en) 1993-06-24
EP0394386A4 (en) 1991-03-13
DK90090D0 (da) 1990-04-10
FI102684B1 (fi) 1999-01-29
FI901879A0 (fi) 1990-04-12
DE68924155T2 (de) 1996-04-18
DE68924155D1 (de) 1995-10-12
DK90090A (da) 1990-04-10
EP0394386B1 (en) 1995-09-06

Similar Documents

Publication Publication Date Title
GR3015269T3 (en) Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use.
HK1000969A1 (en) Method for producing native hiv gp160
AU3332089A (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
GB2218421B (en) A process for producing envelope protein of japanese encephalitis virus using recombinant baculovirus; envelope proteins,recombinant baculovirus and vaccines
CA2055463A1 (en) Antiviral therapy using thiazine and xanthene dyes
JPS5753410A (en) A type hepatitis virus high value production
CA2135630A1 (en) Hiv protein epitopes immunologically homologous to hla
NZ239948A (en) Hiv gp160 modified at positions 502 and 510, vaccines and recombinant methods for producing modified gp160
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
EP0323157A3 (en) Antiviral compounds and methods
EP0184331A3 (en) Psoralen inactivation of human t-cell leukemia virus iii (htlv iii)
AU7512287A (en) Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof
GR3018918T3 (en) Artificial viral envelopes
DK135588A (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
AU3335689A (en) Recombinant gag precursor of hiv, product, process, and use as aids vaccine
ZA913909B (en) Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i(hiv-1)gpl20 and methods of use
GB2239799B (en) Vaccine
PT85602A (en) Oxolabdanes a process for their preparation and their use as medicaments
ZA893085B (en) Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
AU7928187A (en) Hepatitis A vaccine, derived and grown exclusively from cells of human origin
ZA892996B (en) Recombinant gag precursor of hiv,product,process,and use as aids vaccine
HK110095A (en) Anti-hiv activity of bv-3608
UA13734A (uk) Спосіб одержаhhя імуhогеhу, який стимулює імуhhу систему людиhи, заражеhої hiv

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090809